A

s new digital tools from wearables to electronic health records to boxes that can track patients’ movements in their homes promise to reshape health care, it is crucial to scrutinize the massive amount of data being generated to ensure that interventions are actually improving health outcomes.

That was a takeaway message from a group of regulatory and drug development experts at a conference held at MIT on Friday focused on how digital health and artificial intelligence are affecting translational medicine.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.